ch.oddb.org
 
Apotheken | Doctor | Drugs | Hospital | Interactions | MiGeL | Registration owner | Services
Home<List for "R03D" (65)–Sort according to Concentration, Size and Price
     ProductPackage SizeEFPCPSBDCCompositionRegistr. HolderCategory  
What is an ATC-Code?ATC-Overview
Aminophylline (R03DA05) 5 products WHO-DDD DrugBank.ca 
  IP  Aminophyllin Amino10 x 10 mlk.A.Amino AG, Fabrikation
pharmazeutischer und
chemischer Produkte		● BG
  IP  Escophyllin i.v.5 ampoule(s) à 10 ml3.358.05k.A.Injection solution: Theophyllinum 190 mgG. Streuli & Co. AGB / SOG
  IP  Escophyllin i.v.10 ampoule(s) à 10 ml13.35k.A.Injection solution: Theophyllinum 190 mgG. Streuli & Co. AGBG
  IP  Escophyllin i.v.50 ampoule(s) à 10 ml44.45k.A.Injection solution: Theophyllinum 190 mgG. Streuli & Co. AGBG
  IPCI Phyllotemp Continus 22560 Tablet(s)12.7427.30k.A.Delayed release tablets: Theophyllinum Et Ethylendiaminum 225 mgMundipharma Medical
Company		BG
Montelukast (R03DC03) 36 products WHO-DDD DrugBank.ca 
  IPCICMLukair 4 mg28 Tablet(s)18.4636.4010 %Chewing tablets: Montelukastum 4 mgOrganon GmbHB / SL / SOG
  IPCICMLukair 4 mg98 Tablet(s)64.7186.4010 %Chewing tablets: Montelukastum 4 mgOrganon GmbHB / SL / SOG
  IPCICMLukair 5 mg28 Tablet(s)18.3936.3010 %Chewing tablets: Montelukastum 5 mgOrganon GmbHB / SL / SOG
  IPCICMLukair 5 mg98 Tablet(s)64.4886.2010 %Chewing tablets: Montelukastum 5 mgOrganon GmbHB / SL / SOG
  IPCICMLukair 4 mg28 Sachet(s)19.8737.8520 %Granulate: Montelukastum 4 mgOrganon GmbHB / SL / SOG
  IPCICMLukair 10 mg28 Tablet(s)18.3936.3510 %Coated tablets: Montelukastum 10 mgOrganon GmbHB / SL / SOG
  IPCICMLukair 10 mg98 Tablet(s)64.4886.2010 %Coated tablets: Montelukastum 10 mgOrganon GmbHB / SL / SOG
  IPCI Singulair28 Tablet(s)18.4736.4010 %Coated tablets: Montelukastum 10 mgOrganon GmbHB / SL / SOG
  IPCI Singulair98 Tablet(s)64.4886.2010 %Coated tablets: Montelukastum 10 mgOrganon GmbHB / SL / SOG
  IPCI Singulair 5 mg28 Tablet(s)18.4736.4010 %Kautabletten für Kinder: Montelukastum 5 mgOrganon GmbHB / SL / SOG
  IPCI Singulair 5 mg98 Tablet(s)64.4886.2010 %Kautabletten für Kinder: Montelukastum 5 mgOrganon GmbHB / SL / SOG
  IPCI Singulair 4 mg28 Tablet(s)18.4636.4010 %Kautabletten für Kleinkinder: Montelukastum 4 mgOrganon GmbHB / SL / SOG
  IPCI Singulair 4 mg98 Tablet(s)64.4486.1510 %Kautabletten für Kleinkinder: Montelukastum 4 mgOrganon GmbHB / SL / SOG
  IPCI Montelukast Sandoz 4 mg28 Tablet(s)16.7934.7010 %Chewing tablets: Montelukastum 4 mgSandoz
Pharmaceuticals AG		B / SL / SGG
  IPCI Montelukast Sandoz 4 mg98 Tablet(s)58.6280.1510 %Chewing tablets: Montelukastum 4 mgSandoz
Pharmaceuticals AG		B / SL / SGG
  IPCI Montelukast Sandoz 5 mg28 Tablet(s)16.7934.7010 %Chewing tablets: Montelukastum 5 mgSandoz
Pharmaceuticals AG		B / SL / SGG
  IPCI Montelukast Sandoz 5 mg98 Tablet(s)58.6280.1510 %Chewing tablets: Montelukastum 5 mgSandoz
Pharmaceuticals AG		B / SL / SGG
  IPCI Montelukast Spirig HC 428 Tablet(s)16.8034.7010 %Chewing tablets: Montelukastum 4 mgSpirig HealthCare AGB / SL / SGG
  IPCI Montelukast Spirig HC 498 Tablet(s)58.6280.1510 %Chewing tablets: Montelukastum 4 mgSpirig HealthCare AGB / SL / SGG
  IPCI Montelukast Spirig HC 528 Tablet(s)16.8034.7010 %Chewing tablets: Montelukastum 5 mgSpirig HealthCare AGB / SL / SGG
  IPCI Montelukast Spirig HC 598 Tablet(s)58.6280.1510 %Chewing tablets: Montelukastum 5 mgSpirig HealthCare AGB / SL / SGG
  IPCI Montelukast-Mepha 4 mg28 Tablet(s)16.7934.7010 %Chewing tablets: Montelukastum 4 mgMepha Pharma AGB / SL / SGG
  IPCI Montelukast-Mepha 4 mg98 Tablet(s)58.6280.1510 %Chewing tablets: Montelukastum 4 mgMepha Pharma AGB / SL / SGG
  IPCI Montelukast-Mepha 5 mg28 Tablet(s)16.7934.7010 %Chewing tablets: Montelukastum 5 mgMepha Pharma AGB / SL / SGG
  IPCI Montelukast-Mepha 5 mg98 Tablet(s)58.6280.1510 %Chewing tablets: Montelukastum 5 mgMepha Pharma AGB / SL / SGG
  IPCI Montelukast Sandoz 428 Sachet(s)16.7934.7010 %Granulate: Montelukastum 4 mgSandoz
Pharmaceuticals AG		B / SL / SGG
  IPCI Montelukast-Mepha 428 piece(s)16.7934.7010 %Granulate: Montelukastum 4 mgMepha Pharma AGB / SL / SGG
  IPCI Montelukast Sandoz 10 mg28 Tablet(s)16.7934.7010 %Coated tablets: Montelukastum 10 mgSandoz
Pharmaceuticals AG		B / SL / SGG
  IPCI Montelukast Sandoz 10 mg98 Tablet(s)58.6280.2010 %Coated tablets: Montelukastum 10 mgSandoz
Pharmaceuticals AG		B / SL / SGG
  IPCI Montelukast Spirig HC 103018.0035.9510 %Coated tablets: Montelukastum 10 mgSpirig HealthCare AGB / SL / SGG
  IPCI Montelukast Spirig HC 1010059.8281.4010 %Coated tablets: Montelukastum 10 mgSpirig HealthCare AGB / SL / SGG
  IPCI Montelukast Zentiva 10 mg2816.7034.6010 %Coated tablets: Montelukastum 10 mgHelvepharm AGB / SL / SGG
  IPCI Montelukast Zentiva 10 mg9858.6280.2010 %Coated tablets: Montelukastum 10 mgHelvepharm AGB / SL / SGG
  IPCI Montelukast-Mepha 10 mg28 Tablet(s)16.7934.7010 %Coated tablets: Montelukastum 10 mgMepha Pharma AGB / SL / SGG
  IPCI Montelukast-Mepha 10 mg98 Tablet(s)58.6280.2010 %Coated tablets: Montelukastum 10 mgMepha Pharma AGB / SL / SGG
  IPCI Singulair 4 mg28 Sachet(s)19.9637.95k.A.Granulate: Montelukastum 4 mgOrganon GmbHBG
Omalizumab (R03DX05) 12 products WHO-DDD DrugBank.ca 
L IPCI Xolair 75 mg/0.5 ml 166.63194.9010 %Injection solution in prefilled syringe: Omalizumabum 75mg / 0.5mlNovartis Pharma
Schweiz AG		B / SLG
L IPCI Xolair 75 mg/0.5 ml 166.63194.9010 %Injection solution in prefilled syringe: Omalizumabum 75mg / 0.5mlNovartis Pharma
Schweiz AG		B / SLG
L IPCI Xolair 150 mg/1.0 ml 333.25373.3510 %Injection solution in prefilled syringe: Omalizumabum 150mg / 1mlNovartis Pharma
Schweiz AG		B / SLG
L IPCI Xolair 150 mg/1.0 ml 333.25373.3510 %Injection solution in prefilled syringe: Omalizumabum 150mg / 1mlNovartis Pharma
Schweiz AG		B / SLG
L IPCI Xolair 300 mg/2 ml 666.50741.2510 %Injection solution in prefilled syringe: Omalizumabum 300mg / 2mlNovartis Pharma
Schweiz AG		B / SLG
LSIPIPCI Xolair 150 mgampoule(s)333.25373.3510 %Lyophilisate and solvent: Omalizumabum 150 mgNovartis Pharma
Schweiz AG		B / SLG
L IPCI Xolair 150 mg/1.0 ml 333.25373.3510 %Injektionslösung in einem Fertigpen: Omalizumabum 150 mg/mlNovartis Pharma
Schweiz AG		B / SLG
L IPCI Xolair 300 mg/2.0 ml 666.50741.2510 %Injektionslösung in einem Fertigpen: Omalizumabum 300mg / 2mlNovartis Pharma
Schweiz AG		B / SLG
L IPCI Omlyclo 75 mg/0.5 ml 122.15149.2510 %solution injectable en seringue préremplie: Omalizumabum 75mg / 0.5mliQone Healthcare
Switzerland SA		B / SLG
L IPCI Omlyclo 150 mg/1 ml 244.29282.1010 %solution injectable en seringue préremplie: Omalizumabum 150 mg/mliQone Healthcare
Switzerland SA		B / SLG
 SIPIPCI Xolair 75 mgampoule(s)k.A.Lyophilisate and solvent: Omalizumabum 75 mgNovartis Pharma
Schweiz AG		BG
  IPCI Xolair 75 mg/0.5 ml k.A.Injektionslösung in einem Fertigpen: Omalizumabum 75mg / 0.5mlNovartis Pharma
Schweiz AG		BG
Roflumilast (R03DX07) 2 products WHO-DDD DrugBank.ca 
  IPCI Daxas 500 ug30 Tablet(s)54.0675.2010 %Coated tablets: Roflumilastum 500 µgAstraZeneca AGB / SLG
  IPCI Daxas 500 ug90 Tablet(s)137.85166.3510 %Coated tablets: Roflumilastum 500 µgAstraZeneca AGB / SLG
Reslizumab (R03DX08) 2 products WHO-DDD  
L IP  Cinqaero 100 mg/10 mL 510.32571.4010 %Concentrate for infusion: Reslizumabum 100mg / 10mlTeva Pharma AGB / SLG
L IP  Cinqaero 25 mg/2,5 mL 127.59155.2010 %Concentrate for infusion: Reslizumabum 25mg / 2.5mlTeva Pharma AGB / SLG
Mepolizumab (R03DX09) 2 products WHO-DDD  
L IPCI Nucala 100 mg/mL 976.631078.5510 %Injektionslösung im Fertigpen: Mepolizumabum 100mg / 1mlGlaxoSmithKline AGB / SLG
L IPCI Nucala 100 mg/mL 976.631078.5510 %Injektionslösung in der Fertigspritze: Mepolizumabum 100mg / 1mlGlaxoSmithKline AGB / SLG
Benralizumab (R03DX10) 2 products WHO-DDD  
L IPCI Fasenra 30 mg /1 ml 1929.052114.3510 %Injection solution in prefilled syringe: Benralizumabum 30 mg/mlAstraZeneca AGB / SLG
L IPCI Fasenra Pen 30 mg /1 ml 1929.052114.3510 %lnjektionslösung: Benralizumabum 30 mg/mlAstraZeneca AGB / SLG
Tezepelumab (R03DX11) 2 products WHO-DDD  
L IPCI Tezspire 1036.421143.6010 %Injection solution in prefilled syringe: Tezepelumabum 210 mgAstraZeneca AGB / SLG
L IPCI Tezspire 110 mg/ml 1036.421143.6010 %Injektionslösung in einem Fertigpen: Tezepelumabum 210 mgAstraZeneca AGB / SLG
(R03DZ) 2 products WHO-DDD  
   CIHRegenaplex Nr. 24c15 mlk.A.Tropfen zum Einnehmen: 10 Active AgentsRegena AGDG
   CIHRegenaplex Nr. 24b15 mlk.A.Tropfen zum Einnehmen: 10 Active AgentsRegena AGDG
 
ATC-Browser | Drugs A-Z | Recent Registrations
2026 ©ywesee GmbH
Settings | Help | Login | Contact | Home